Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

397 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Primary Aldosteronism: Novel Insights.
Stavropoulos K, Imprialos K, Papademetriou V, Faselis C, Tsioufis K, Dimitriadis K, Doumas M. Stavropoulos K, et al. Among authors: tsioufis k. Curr Hypertens Rev. 2020;16(1):19-23. doi: 10.2174/1573402115666190415155512. Curr Hypertens Rev. 2020. PMID: 30987572 Review.
Differential effects of lercanidipine/enalapril versus amlodipine/enalapril and hydrochlorothiazide/enalapril on target organ damage and sympathetic activation in non-obese essential hypertensive subjects.
Tsioufis K, Tsioufis C, Dimitriadis K, Mantzouranis E, Mani I, Tousoulis D. Tsioufis K, et al. Among authors: tsioufis c. Curr Med Res Opin. 2016 Oct;32(sup2):35-41. doi: 10.1080/03007995.2016.1218839. Curr Med Res Opin. 2016. PMID: 27779461 Clinical Trial.
Air pollution and arterial hypertension. A new risk factor is in the air.
Sanidas E, Papadopoulos DP, Grassos H, Velliou M, Tsioufis K, Barbetseas J, Papademetriou V. Sanidas E, et al. Among authors: tsioufis k. J Am Soc Hypertens. 2017 Nov;11(11):709-715. doi: 10.1016/j.jash.2017.09.008. Epub 2017 Sep 27. J Am Soc Hypertens. 2017. PMID: 28989071 Review.
Labile hypertension: a new disease or a variability phenomenon?
Sanidas E, Grassos C, Papadopoulos DP, Velliou M, Tsioufis K, Mantzourani M, Perrea D, Iliopoulos D, Barbetseas J, Papademetriou V. Sanidas E, et al. Among authors: tsioufis k. J Hum Hypertens. 2019 Jun;33(6):436-443. doi: 10.1038/s41371-018-0157-8. Epub 2019 Jan 15. J Hum Hypertens. 2019. PMID: 30647464 Review.
Pharmacological Management of Diabetic Nephropathy.
Papademetriou V, Alataki S, Stavropoulos K, Papadopoulos C, Bakogiannis K, Tsioufis K. Papademetriou V, et al. Among authors: tsioufis k. Curr Vasc Pharmacol. 2020;18(2):139-147. doi: 10.2174/1570161117666190405164749. Curr Vasc Pharmacol. 2020. PMID: 30961500 Review.
Cardiovascular, renal and liver protection with novel antidiabetic agents beyond blood glucose lowering in type 2 diabetes: consensus article from the European Society of Hypertension Working Group on Obesity, Diabetes and the High-risk Patient.
Kotsis V, Jordan J, Stabouli S, Antza C, Micic D, Jelaković B, Schlaich MP, Nilsson PM, Kreutz R, Mancia G, Tsioufis K, Grassi G. Kotsis V, et al. Among authors: tsioufis k. J Hypertens. 2020 Mar;38(3):377-386. doi: 10.1097/HJH.0000000000002279. J Hypertens. 2020. PMID: 31764586
397 results